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Previewsaccomplished through epidemiological
methods that look for altered signs
of transmission or virulence in the
human population. However, additional
genetic and molecular experimental
approaches will be needed to be sure
that what is happening in the human pop-
ulation is related to changes in viral ge-
netics. Ongoing monitoring of specimens
collected for diagnostic purposes should
be performed. Virological studies com-
paring the replication of EBOV isolates
with different genetic sequences can
also be performed, but this requires
biosafety level 4 containment labs. Addi-
tionally, assays that recapitulate themajor
steps in the virus replication cycle are
available and can be employed.
Collecting specimens from EBOV pa-
tients comes with risk and, tragically,
four coauthors on the Science paper con-
tracted and succumbed to EBOVdisease.
Gire and colleagues can be commended
for rapidly determining these viral se-
quences and for publically releasing the
data as they became available (Gire
et al., 2014). This openness facilitates
public health efforts to contain theepidemic and scientific efforts to under-
stand it. The sequences that have been
reported thus far were collected up until
mid-June. Therefore, nearly three months
of continuing transmission have elapsed
with no significant new sequence data
made available through public databases.
Hopefully, the genetic material collected
for diagnostic purposes will also be put
to good use to better understand and
respond to the ongoing and tragic
epidemic.
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A small number of tissue-resident memory T cells (Trm) provide potent protection against infections. Three
recent studies by Ariotti et al. (2014), Schenkel et al. (2014a), and Iijima and Iwasaki (2014) report that Trm
rapidly produce cytokines after infection and initiate a tissue-wide anti-viral state by instructing innate
immune cells.Cells of the innate immune system such
as macrophages, neutrophils, and den-
dritic cells rapidly respond to infection
by phagocytosing and destroying mi-
crobes. Additionally, these cells are
capable of initiating a tissue-wide inflam-matory/anti-microbial state when they
sense danger through their pattern re-
cognition receptors (PRRs). PRRs are
not specific for a particular pathogen
antigen but recognize common microbial
traits (e.g., LPS from gram negative bac-teria, unmethylated CpG DNA from bac-
teria and DNA viruses). T cells, on the
other hand, can provide a very specific
response through their clonal T cell recep-
tors and are pivotal in the elimination
intracellular pathogens. However, naı¨ve6, October 8, 2014 ª2014 Elsevier Inc. 421
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Figure 1. Trm Are Maintained through a Network of Local Macrophages and Initiate a Local
Anti-Viral State upon Re-Infection
When an epithelium is re-infected, Trm can quickly detect infected epithelial cells (red) and respond by pro-
ducing cytokines. These cytokines induce a tissue wide anti-viral state (blue). Moreover, Trm-derived IFN-g
promotes additional lymphocyte recruitment by inducing upregulation of the adhesion molecule VCAM-1,
TNF-a promotes DCmaturation, and IL-2 induces activation of NK cells. During steady state, Trmmay pro-
duce a low level of IFN-g that does not induce an anti-viral state but is sufficient to induce CCL5 production
by local macrophages. CCL5 in turn may prevent shedding of Trm into the lumen.
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Previewsantigen-specific T cells rely on the innate
immune system for proper instruction, as
these cells are relatively infrequent and
cannot enter most non-lymphoid tissues.
Naı¨ve T cell activation is instructed by
interactions with mature dendritic cells
expressing cognate antigens in the
context of MHCI or MCHII molecules
with additional information provided by
costimulatory interactions and inflam-
matory cytokines. Upon integration of
these specific instructions, T cells greatly
expand in number and acquire the ca-
pacity to infiltrate infected tissues. Most
of these T cells will die by apoptosis
after the infection is cleared; however,
some will persist as memory T cells and
spread throughout the circulation. In
recent years it has become evident that
a subset of these memory T cells can
stay behind in the previously infected tis-
sue. These memory cells are referred to
as tissue-resident memory T cells (Trm)
and are found at many sites that are prone
to reinfection (skin, lung, intestine, and
reproductive tract). Systemic depletion
experiments have shown that Trm do not
circulate and are maintained indepen-
dently of the circulating memory T cell
population. Importantly, various reports
using parabiotic mice show that Trm’s
proximity to the site of infection allows
superior protection to homologous infec-
tion compared to circulating memory
T cells. How a small number of Trm pro-
vide such potent protection, however,
has remained unclear.
In a recent issue of Science, three
groups independently report that Trm can
turn the tables and rapidly become in-422 Cell Host & Microbe 16, October 8, 2014structors of the innate immune system.
Ariotti et al. (2014) report that herpes sim-
plex virus 1 (HSV-1)-specific CD8+ Trm in
the skin rapidly initiate a local anti-viral
state after infection with HSV-1. In mice
containing Trm, an upregulation of genes
involved in inflammation and innate im-
munity was observed as early as 3 hr
post infection, which was not observed
in skin devoid of Trm or that contained
Trm that were unable to produce IFN-g.
Schenkel et al. (2014a) found that CD8+
Trm in the murine female reproductive
tract produce IFN-g, TNF-a, and IL-2
within 12 hr after vaginal vaccinia infec-
tion. These cytokines have distinct func-
tions in initiating an anti-viral state in
the female reproductive tract (Figure 1).
Trm-derived IFN-g drives the expression
of the adhesion molecule VCAM-1 on
endothelial cells in the reproductive tract
and mediates concurrent recruitment
of B cells. TNF-a induces dendritic cell
maturation and IL-2 activates NK-cells.
Finally, Iijima and Iwasaki (2014) show
that not only CD8 Trm but also CD4 Trm
rapidly produce IFN-g and mediate pro-
tection against HSV-2 infection in the gen-
ital mucosa. These findings suggest that
Trm can act as pathogen-specific senti-
nels in the periphery, making these cells
conceptually similar to innate cells that
use PRR to detect infection. Their prox-
imity to newly infected cells and their
propensity to produce proinflammatory
cytokines allows Trm to rapidly initiate an
innate immune response in the infected
tissue. The idea that a small number of
antigen-specific T cells in the right place
can provide protection without the needª2014 Elsevier Inc.for a large systemic memory T cell popu-
lation is enticing with regard to vaccine
development, as the generation of large
memory T cell populations in humans
has often proven difficult.
How best to generate and maintain Trm
remains unclear as these populations
are only observed after local infection.
For instance, vaccinia virus administration
through skin scarification results in a Trm
population in the epidermis, which is
not observed with vaccinia virus adminis-
tered through a systemic route (Jiang
et al., 2012). Recent studies suggest that
responding T cells receive signals in
the local microenvironment that permit
adoption of a phenotype compatible
with that particular tissue (Wakim et al.,
2010). Microarray studies indeed show
various transcriptional differences be-
tween circulating memory T cells and
Trm but also between Trm from different
tissues (Mackay et al., 2013), suggesting
the signals Trm receive are different for
every tissue. Despite these differences,
some commonalities can be observed. A
pivotal transformation for Trm is downre-
gulation of the transcription factor KLF-2
and expression of the transmembrane
C-type lectin CD69 (Skon et al., 2013).
CD69 inhibits S1P receptor signaling
that controls T cell migration and thus pre-
vents Trm from exiting the tissue. Cyto-
kines that are abundant in infected tissue
including TGF-b, TNF-a, and IL-33 can
sustain KLF-2 downregulation and thus
sustain Trm (Skon et al., 2013). However,
it is unknown whether all effector T cells
are susceptible to Trm transformation, as
some studies suggest terminally differen-
tiated effector (KLRG1+) CD8 T cells do
not become Trm (Mackay et al., 2013).
TGF-b is constitutively expressed in
most tissues and thus may be a key cyto-
kine in the long-term maintenance of Trm.
TGF-b is also the driving force behind
another key adaptation of Trm, expression
of aE integrin (CD103). aE integrin can
form a heterodimer with b7 integrin and
act a ligand for E-cadherin. As E-cadherin
is expressed in various epithelia, expres-
sion of CD103 may aid permanent resi-
dency of Trm in the epithelium. In that
respect, it is interesting that a recently
described lymphoid Trm population does
not express CD103 (Schenkel et al.,
2014b). As an alternative hypothesis, Ii-
jima and Iwasaki (2014) suggest that
a local network of macrophages
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Previewssustains Trm. Depletion of cells expressing
CD11b+, a marker for macrophages, led
to a reduction in CD4+ (and CD8+) Trm as
did blockade of the chemokine CCL5.
Moreover, Iijima and Iwaski detected
CD4+ Trm that produce a low level of
IFN-g ex vivo without the need for restim-
ulation with peptide. They propose a
model where Trm-derived-IFN-g induces
local macrophages to produce CCL5,
which in turn prevents Trm from being
expulsed into the vaginal lumen (Figure 1).
Thus, Trm not only instruct innate immune
cells upon infection but keep instructing
them in order to maintain themselves at
the initial site of infection.
These three recent reports (Ariotti et al.,
2014; Iijima and Iwasaki, 2014; Schenkel
et al., 2014a) show the potential power
and precision Trm may provide to protect
against specific infections. In order to
translate these findings into effective vac-
cine strategies, we will need a more
comprehensive understanding of how to
maximize the number of Trm and to pro-
long their longevity in a specific tissue.
The complexity of Trm is substantial asCD4+ and CD8+ T cells behave differently
and the maintenance of Trm is very tissue
specific. For instance, it is unlikely that
expulsion into the lumen is a major
concern for skin Trm, whereas the large
surface area of the lung may require
active repression of Trm shedding into
the lung airways. On that note, the
longevity of Trm appears to greatly differ
between tissues as skin Trm are main-
tained in mice for over a year (Mackay
et al., 2012), whereas lung Trm may only
be detectable for a few months (Wu
et al., 2013). Despite these challenges,
vaccine-induced Trm could be worth the
effort, particularly in the case of patho-
gens such as HIV, where rapid induction
of an antiviral state by Trm could be pivotal
to prevent systemic dissemination.REFERENCES
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During its developmental transformation in the mammalian host, Trypanosma cruzi discards it flagellum into
the cytoplasm of the host cell. In the current issue of Cell Host & Microbe, Kurup and Tarleton (2014) exploit
the antigens made available by this process to develop a more effective vaccine strategy.The Kinetoplastid protozoan parasites
that include African trypanosomes, Trypa-
nosma cruzi, and various Leishmania sp.
produce a spectrum of human and veter-
inary diseases that continue to pose enor-
mous public health concerns throughout
tropical and subtropical regions. Impor-
tantly, there are no effective vaccines
against any of these vector-borne dis-
eases. A major impediment to vaccine
development is the complexity of the
antigens that these eukaryotic pathogens
offer as immunologic targets and theirremarkable adaptability to immunologic
pressure. Thus, the large genome sizes
and proteomes possessed by these para-
sites may preclude responses to anything
but a few immunodominant epitopes
encoded by genes that are driven to
display extensive allelic or somatic poly-
morphisms. In the current studies, Kurup
and Tarleton (2014) develop a strategy to
identify invariant, subdominant, and early
antigens targets that can be incorporated
into a live, attenuated vaccine to poten-
tiate a protective response.Trypanosma cruzi is the causative agent
of Chagas disease, which is the most
prevalent cause of infectious myocarditis
in Central and South America. The basic
life cycle of Trypanosma cruzi was
described by Carlos Chagas over one
century ago (Chagas, 1909) and is sum-
marized in Figure 1.Metacyclic trypomas-
tigotes are the flagellated, extracellular-
stage parasites that are excreted by an
infected reduviid bug. The excreta can
contaminate the bite wound or mucous
membranes, allowing the metacyclics to6, October 8, 2014 ª2014 Elsevier Inc. 423
